Bidvest challenges CFR's offer for Adcock

5 December 2013 - Deborah Wilkes


A consortium led by Bidvest is challenging CFR Pharmaceuticals' plan to purchase South African pharmaceutical company Adcock Ingram in a cash and share deal worth ZAR12.6 billion (US$1.30 billion).

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: